Cargando…
Gut Microbiome-Derived Uremic Toxin Levels in Hemodialysis Patients on Different Phosphate Binder Therapies
INTRODUCTION: Constipation is prevalent in patients with kidney failure partly due to the use of medication, such as phosphate binders. We hypothesized that serum levels of gut microbiome-derived uremic toxins (UTOX) may be affected by the choice of phosphate binder putatively through its impact on...
Autores principales: | Wang, Lin-Chun, Tapia, Leticia M., Tao, Xia, Chao, Joshua E., Thwin, Ohnmar, Zhang, Hanjie, Thijssen, Stephan, Kotanko, Peter, Grobe, Nadja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393811/ https://www.ncbi.nlm.nih.gov/pubmed/34375976 http://dx.doi.org/10.1159/000517470 |
Ejemplares similares
-
SARS-CoV-2 Seropositivity Rates in Patients and Clinical Staff in New York City Dialysis Facilities: Association With the General Population
por: Thwin, Ohnmar, et al.
Publicado: (2021) -
Removal of Protein-Bound Uremic Toxins Using Binding Competitors in Hemodialysis: A Narrative Review
por: Maheshwari, Vaibhav, et al.
Publicado: (2021) -
A novel mathematical model of protein-bound uremic toxin kinetics during hemodialysis
por: Maheshwari, Vaibhav, et al.
Publicado: (2017) -
In silico comparison of protein-bound uremic toxin removal by hemodialysis, hemodiafiltration, membrane adsorption, and binding competition
por: Maheshwari, Vaibhav, et al.
Publicado: (2019) -
SARS-CoV-2 neutralizing antibody response after three doses of mRNA1273 vaccine and COVID-19 in hemodialysis patients
por: Wang, Xiaoling, et al.
Publicado: (2022)